English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily reports
| Feb 15, 2021
NeuroRx CEO says Zyesami trial shows promising results for critically ill COVID-19 patients
Bree Gonzales
| Feb 12, 2021
Aviptadil helped doctor who contracted COVID-19 avoid lung transplant
Bree Gonzales
| Feb 12, 2021
Great Plains Health patients treated with Zyesami (aviptadil) show signs of recovery from COVID-19
Press release submission
| Feb 12, 2021
ROCHE: Receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients
Press release submission
| Feb 12, 2021
CARE CAP PLUS: Offers Solution to Benefit Patients and Doctors
Bree Gonzales
| Feb 12, 2021
Zyesami (Aviptadil) helped speed recovery for GPH COVID patient
Patient Daily reports
| Feb 3, 2021
Promising drug helps Florida man with COVID-19
Michael Pineda
| Jan 10, 2021
Pandemic changes the way medical officials approach diabetes
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
American Lung Association launches campaign for World Bronchiectasis Day
« First
«
…
10
11
12
13
14
15
16
…
»
Last »